跳至主要内容
临床试验/NCT06129318
NCT06129318已完成不适用

Investigation of the Effects of Pharmaceutical Care Provided by a Clinical Pharmacist on Stroke Patients

Marmara University1 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2021年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
260
试验地点
1
主要终点
Blood pressure

研究概览

简要总结

To evaluate the effects of the 1-year pharmaceutical care program offered by the clinical pharmacist to the patients admitted to the neurology service with the diagnosis of stroke, on medication adherence, quality of life, and clinical outcomes of the patients.

详细描述

The study was conducted as a parallel randomized controlled study in the Neurology Clinic of a University Hospital in Turkey. Patients were randomly assigned to intervention and usual care groups. While the patients in the usual care group are given routine health services by the neurologist during their hospitalization and for 1 year after discharge; In addition to these routine services, the intervention group was provided with pharmaceutical care by a clinical pharmacist during the same period. The study was always conducted by the same neurologist and clinical pharmacist. Patient medication adherence, quality of life, and clinical parameters were evaluated at the beginning of the study and at the 12th month.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • being diagnosed with stroke,
  • being 18 years old or older,
  • being in the cognition to receive the training to be given

排除标准

  • Not having adequate cognitive function such as dementia,
  • being pregnant, lactating,
  • having cancer.

结局指标

主要结局

Blood pressure

时间窗: 1, 3, 6, 9 and 12 months

Blood pressure was checked and recorded by a qualified nurse during the hospital stay and at control visits. Measurements were recorded as mmHg.

Medication Adherence

时间窗: 3, 6, 9 and 12 months

Adherence to Stroke Prevention Medications (Anti platelets, Anticoagulants, Statins, antihypertensives, antidiabetics) measured by Morisky-Green-Levine Adherence Scale (1-4) where higher scores indicate higher levels of reported adherence.

HbA1c

时间窗: 1, 3, 6, 9 and 12 months

HbA1c (glycated hemoglobin) value was collected from medical records and recorded as a percentage.

LDL cholesterol

时间窗: 1, 3, 6, 9 and 12 months

Low density lipoprotein-cholesterol level was collected from medical records and recorded as mg/dL

Triglyceride

时间窗: 1, 3, 6, 9 and 12 months

Triglyceride level was collected from medical records and recorded as mg/dL.

Body mass index

时间窗: 1, 3, 6, 9 and 12 months

Body mass index (BMI) was collected from medical records and recorded as kg/m2

次要结局

  • Drug Related Problem(1 year)
  • The National Institutes of Health Stroke Scale(24 hours before discharge, 3, 6, 9 and 12 months)
  • Measuring Quality of Life(3, 6 and 12 months)
  • Stroke Recurrence(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mesut Sancar

Prof. Dr.

Marmara University

研究点 (1)

Loading locations...

相似试验